Consortium

Academic sites and industry partners

TRIDENT is a multi-center academic-industry research consortium of nephrologists, renal pathologists, translational scientists and biopharmaceutical partners committed to precision medicine for diabetic kidney disease. Participation has evolved with the phases of the study; a focused group of academic sites now leads enrollment, data generation and analysis.

Active participating sites

Participant enrollment, data contribution and ongoing scientific analyses.

University of PennsylvaniaGaia Coppock, MD

Mayo ClinicEnrolling site, 2026

The Ohio State UniversityBrad Rovin, MD

University of North Carolina at Chapel HillAmy Mottl, MD

Active analysis sites (enrollment complete)

Data contribution, analysis and scientific leadership.

Albert Einstein College of Medicine and Montefiore Medical CenterMichael Ross, MD

Icahn School of Medicine at Mount SinaiKirk Campbell, MD; Michael Ross, MD

Northwestern UniversityTamara Isakova, MD

Stanford UniversityRichard Lafayette, MD

Oregon Health & Science UniversityRupali Avasare, MD

University of New MexicoChristos Argyropoulos, MD

University of VirginiaJulia Scialla, MD

Yale UniversityRandy Luciano, MD

Contributing and legacy sites

Institutions and investigators whose foundational work in earlier phases established the TRIDENT platform and infrastructure.

UT Health San AntonioShweta Bansal, MD

University of MiamiAlessia Fornoni, MD, PhD

University of MichiganMatthias Kretzler, MD

University of ArizonaFrank Brosius, MD

Columbia UniversityPietro Canetta, MD

Lehigh Valley Health NetworkNelson Kopyt, MD

MetroHealth Medical CenterJeff Schelling, MD

Baylor Scott & White Research InstituteHarold Szerlip, MD

Georgia NephrologyJames Tumlin, MD

Industry partners

Current and past collaborators

Boehringer IngelheimNovo NordiskAstraZenecaGenentechGlaxoSmithKlineRegeneronGilead Sciences

Industry partnerships support translational insight, biomarker development and alignment with therapeutic innovation while preserving academic independence and scientific integrity.

Partner with TRIDENT